A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.
about
Drugs for the acute treatment of migraine in children and adolescentsThe optimal management of headaches in children and adolescentsMedication overuse in children and adolescentsEFNS guideline on the drug treatment of migraine - report of an EFNS task forcePain therapy in children and adolescentsEvidence and consensus recommendations for the pharmacological management of pain in India.Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.Migraine headache in children.Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structuresOverview of diagnosis and management of paediatric headache. Part II: therapeutic managementTreatment of paediatric headache.Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007.Triptans for migraine management in adolescents.Intranasal sumatriptan for migraine in children.Parental satisfaction with sumatriptan nasal spray in childhood migraine.Migraine treatment: a chain of adverse effects.Is migraine a risk factor for pediatric stroke?The placebo responder rate in children and adolescents.Sumatriptan: a decade of use and experience in the treatment of migraine.Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification.Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.The treatment of migraine headaches in children and adolescentsPediatric migraine: new diagnostic strategies and treatment options.The pharmacological treatment options for pediatric migraine: an evidence-based appraisal.Sumatriptan: update and review.Peer-reviewed publication of clinical trials completed for pediatric exclusivityNasal delivery of antimigraine drugs: clinical rationale and evidence base.Recommendations for the management of migraine in paediatric patients.Management of migraine in adolescents.Treatment of pediatric migraine in the emergency roomAcute treatment of paediatric migraine: a meta-analysis of efficacy.Predictors of Triptan Response in Pediatric MigraineCurrent therapies in childhood and adolescent migraine.Methods and software for estimating health disparities: the case of children's oral health.Current migraine management - patient acceptability and future approaches.Advances in paediatric migraine.Almotriptan for the acute treatment of adolescent migraine.Triptans other than sumatriptan in child and adolescent migraine: literature review.Pediatric headache: a clinical review.Treating pediatric migraine: an expert opinion.
P2860
Q24185885-E6A1D37A-EA20-431A-80F9-9738D0ABAFDBQ26770813-0C51DAFC-B803-4FAF-8D85-499640C19B7AQ27006583-B4ED58FA-5D0D-4CC9-AF33-BABA85716E1DQ28219436-46CC7278-7CF2-49D0-9F1C-B5F156931F2BQ28752499-3C69A02F-0B17-4CCE-A9AA-5458543F3DEAQ30844805-FD703FAB-C9FD-4A3E-98BD-8F1C5D0A304BQ33160296-DBFCF098-3D19-4E94-A8F2-F1FA2528CB06Q33868355-4881CA75-DFD1-47BE-B557-5CACB8124992Q33941603-FA29414A-CA67-49D9-9F3A-FF994A918D97Q34770791-7380E4E1-3638-420D-8E3D-47E9CBF43507Q34974806-638CAFF2-95A5-4519-B1FD-C3909BE69D2AQ34996953-C472E155-54DA-4D45-95A7-F2DD400B3E3DQ35025918-25CDD49B-4C62-493D-AFC5-1EB2D390061BQ35601543-60FC3663-1C4F-4467-A860-E5E25FD26DEDQ35616987-1771EEA6-001C-4F96-A08E-CE5F71035FC1Q35933207-D23EF626-2587-4C01-BDF4-445B8D39A1C1Q36042589-B601FF09-BA0C-444E-81E5-53904561373FQ36100812-A1181F0C-68FC-4D95-ADA4-6141ED08E0E9Q36107080-7BA3BF0D-E787-4DE4-8B01-0785D9192A98Q36259763-E33E7CEF-DBEF-4591-97B3-98EB913A3E02Q36278708-79C338DD-8DD0-4830-9022-4FD91CDD8708Q36290746-19A2BC2A-BEA0-4A22-80A7-38F129455A06Q36419547-CCFB4A62-FA4E-443E-A883-D6B9FEDE562FQ36428744-7DF3BBAA-0FD7-48B8-89B8-BB615925B2B4Q36543148-855AB8C6-742C-44D0-AFE5-421333D8546BQ36591926-FED5530A-8962-48AF-B12A-23BB4676366CQ36641573-2EAE7D19-A5ED-4E55-ACC8-C59393287207Q36787278-F042A403-68C7-4326-9398-31084DDC5563Q36853954-81E2AFCA-9D0C-4852-B25C-065C0ED3D087Q36925907-8636A963-E9DD-414B-A691-3479D212BC9FQ36940058-2E75F98B-1021-49B5-ADF0-8559F8400AA2Q36984540-001AF653-17CF-48A7-8A15-F56C41D48E74Q37002459-2EB752A9-270E-42DF-8023-1BC31D958029Q37003778-4A4D3A0E-7612-4C97-92BE-4F7A16770ADAQ37106936-7BB37766-2AE2-489D-8D8F-5AC671C20D67Q37479579-16EDCC27-FBC0-46E1-8376-1A6B4AF4E22AQ37786624-19A0524A-F6E1-415F-80B7-E476C30D3F4AQ37849766-47E6AB1B-9994-4F0F-AD97-2658C894142FQ37979834-DD68A624-0202-4127-A29F-F54C1C8B2105Q38002459-BCD7E7CC-2AA7-4F0A-BD27-31E03A75E6AB
P2860
A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... acute migraine in adolescents.
@en
A randomized, double-blind, pl ...... acute migraine in adolescents.
@nl
type
label
A randomized, double-blind, pl ...... acute migraine in adolescents.
@en
A randomized, double-blind, pl ...... acute migraine in adolescents.
@nl
prefLabel
A randomized, double-blind, pl ...... acute migraine in adolescents.
@en
A randomized, double-blind, pl ...... acute migraine in adolescents.
@nl
P2093
P921
P356
P1433
P1476
A randomized, double-blind, pl ...... acute migraine in adolescents.
@en
P2093
Asgharnejad M
Laurenza A
Peykamian M
Rothner AD
P304
P356
10.1542/PEDS.106.5.989
P407
P577
2000-11-01T00:00:00Z